BRIEF published on 08/29/2024 at 17:50, 2 years 2 months ago Median Technologies: eyonis achieves REALITY study objectives Screening Median Technologies Lung Cancer Eyonis™ LCS AUC
BRIEF published on 07/18/2024 at 18:01, 2 years 3 months ago Median Technologies unveils half-year results and strategic advances Artificial Intelligence Turnover Backlog ICRO Eyonis™ LCS
PRESS RELEASE published on 07/18/2024 at 17:56, 2 years 3 months ago Inside Information / News release on accounts, results Median Technologies reports record iCRO backlog and eyonis™ LCS on-track for pivotal study readout in August. Revenue at €10.9 million, cash at €16 million. CEO to provide update via webcast on July 24, 2024 Revenue Growth Median Technologies ICRO Eyonis LCS Pivotal Study
BRIEF published on 06/07/2024 at 17:50, 2 years 4 months ago Changes in Shareholder Voting Rights at Median Technologies Share Capital Voting Rights French Regulations Median Technologies Non-voting Shares
PRESS RELEASE published on 06/07/2024 at 17:45, 2 years 4 months ago Changes in the rights attaching to the classes of shares or securities Median Technologies discloses total voting rights and share capital as of May 31, 2024, in compliance with French regulations. The company specializes in AI-driven solutions for cancer diagnosis and treatment Share Capital Voting Rights AI Solutions Median Technologies Cancer Diagnosis
BRIEF published on 05/29/2024 at 17:50, 2 years 5 months ago Median Technologies to Attend 2024 ASCO Annual Meeting in Chicago Clinical Trials Oncology Imaging Solutions Median Technologies ASCO Annual Meeting
PRESS RELEASE published on 05/29/2024 at 17:45, 2 years 5 months ago Inside Information / Other news releases Median Technologies to participate in the 2024 ASCO Annual Meeting at McCormick Place, Chicago, IL, USA. Abstract on double reading performance in lung clinical trials. Event details and company overview Clinical Trials Oncology Medical Imaging Median Technologies ASCO Annual Meeting
BRIEF published on 05/21/2024 at 17:50, 2 years 5 months ago Median Technologies strengthens its position with pharmaceutical giants Artificial Intelligence Oncology Medical Imaging Median Technologies Clinical Tests
BRIEF published on 05/10/2024 at 17:50, 2 years 5 months ago Median Technologies Announces Update on Shares Voting Rights Voting Rights Median Technologies Share Structure French Corporate Law Non-voting Shares
PRESS RELEASE published on 05/10/2024 at 17:45, 2 years 5 months ago Changes in the rights attaching to the classes of shares or securities Press release about disclosing the total number of voting rights and shares in Median Technologies as of April 30th, 2024 Voting Rights Shares Median Technologies Innovative Imaging Solutions French SME Equity
Published on 11/04/2026 at 23:10, 5 hours 21 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 5 hours 31 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 6 hours 16 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 6 hours 26 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 04:15, 16 minutes ago From Aba to Paris: Hearth Light Opens a New Chapter in International Intangible Cultural Heritage Exchange
Published on 11/05/2026 at 04:00, 31 minutes ago Andamanda Phuket: A Must-Visit Water Park for Family Holiday
Published on 11/05/2026 at 03:55, 36 minutes ago AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Published on 11/05/2026 at 03:10, 1 hour 21 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 4 hours 28 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 18:00, 10 hours 31 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 17:44, 10 hours 47 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Published on 11/04/2026 at 11:56, 16 hours 34 minutes ago Mersen: Number of shares and voting rights as of October 31, 2026
